Published in Circulation on April 24, 2001
Thrombospondin-1 inhibits endothelial cell responses to nitric oxide in a cGMP-dependent manner. Proc Natl Acad Sci U S A (2005) 2.17
Role of beta2-integrins for homing and neovascularization capacity of endothelial progenitor cells. J Exp Med (2004) 2.04
OxLDL-dependent activation of arginase II is dependent on the LOX-1 receptor and downstream RhoA signaling. Atherosclerosis (2010) 1.12
Matrix metalloproteinase 13 mediates nitric oxide activation of endothelial cell migration. Proc Natl Acad Sci U S A (2005) 1.02
Induction of angiogenesis by heat shock protein 90 mediated by protein kinase Akt and endothelial nitric oxide synthase. Arterioscler Thromb Vasc Biol (2004) 1.01
Posttranslational modification of constitutive nitric oxide synthase in the penis. J Androl (2009) 0.98
Redox Roles of Reactive Oxygen Species in Cardiovascular Diseases. Int J Mol Sci (2015) 0.91
Retracted Cigarette-smoke-induced oxidative/nitrosative stress impairs VEGF- and fluid-shear-stress-mediated signaling in endothelial cells. Antioxid Redox Signal (2010) 0.90
Endothelial progenitor cells: what use for the cardiologist? J Angiogenes Res (2010) 0.89
Molecular regulation of tumor angiogenesis and perfusion via redox signaling. Chem Rev (2009) 0.89
Macrophages transmit potent proangiogenic effects of oxLDL in vitro and in vivo involving HIF-1α activation: a novel aspect of angiogenesis in atherosclerosis. J Cardiovasc Transl Res (2013) 0.87
Akt pathway is hypoactivated by synergistic actions of diabetes mellitus and hypercholesterolemia resulting in advanced coronary artery disease. Am J Physiol Heart Circ Physiol (2010) 0.86
EPC-derived microvesicles protect cardiomyocytes from Ang II-induced hypertrophy and apoptosis. PLoS One (2014) 0.85
Current therapeutic strategies to mitigate the eNOS dysfunction in ischaemic stroke. Cell Mol Neurobiol (2011) 0.85
Ox-LDL modifies the behaviour of bone marrow stem cells and impairs their endothelial differentiation via inhibition of Akt phosphorylation. J Cell Mol Med (2011) 0.85
Thalidomide inhibits inflammatory and angiogenic activation of human intestinal microvascular endothelial cells (HIMEC). Am J Physiol Gastrointest Liver Physiol (2009) 0.82
The critical role of Akt in cardiovascular function. Vascul Pharmacol (2015) 0.81
The protective effect of Bcl-xl overexpression against oxidative stress-induced vascular endothelial cell injury and the role of the Akt/eNOS pathway. Int J Mol Sci (2013) 0.80
Assessing cardiovascular risk in hepatitis C: An unmet need. World J Hepatol (2015) 0.80
Oxidized LDL signals through Rho-GTPase to induce endothelial cell stiffening and promote capillary formation. J Lipid Res (2016) 0.79
Dihydroartemisinin inhibits vascular endothelial growth factor-induced endothelial cell migration by a p38 mitogen-activated protein kinase-independent pathway. Exp Ther Med (2014) 0.79
Potent inhibition of VEGFR-2 activation by tight binding of green tea epigallocatechin gallate and apple procyanidins to VEGF: relevance to angiogenesis. Mol Nutr Food Res (2015) 0.79
Inhibition of endothelial Slit2/Robo1 signaling by thalidomide restrains angiogenesis by blocking the PI3K/Akt pathway. Dig Dis Sci (2014) 0.78
Oxidized low-density lipoproteins impair endothelial function by inhibiting non-genomic action of thyroid hormone-mediated nitric oxide production in human endothelial cells. Thyroid (2013) 0.77
Mesenchymal Stem Cells Ameliorate Atherosclerotic Lesions via Restoring Endothelial Function. Stem Cells Transl Med (2014) 0.76
Reactive Oxygen Species: A Key Hallmark of Cardiovascular Disease. Adv Med (2016) 0.76
Oxidized low-density lipoprotein decreases VEGFR2 expression in HUVECs and impairs angiogenesis. Exp Ther Med (2016) 0.75
TIFA as a crucial mediator for NLRP3 inflammasome. Proc Natl Acad Sci U S A (2016) 0.75
LDL suppresses angiogenesis through disruption of the HIF pathway via NF-κB inhibition which is reversed by the proteasome inhibitor BSc2118. Oncotarget (2015) 0.75
Lovastatin exerts protective effects on endothelial cells via upregulation of PTK2B. Exp Ther Med (2016) 0.75
OxLDL-induced endothelial proliferation via Rho/ROCK/Akt/p27(kip1) signaling: prevention by cholesterol loading. Am J Physiol Cell Physiol (2017) 0.75
Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature (1999) 13.73
Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res (2001) 8.62
Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation (2000) 6.13
HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. J Clin Invest (2001) 4.11
Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site. J Clin Invest (2001) 3.46
Phosphorylation of Thr(495) regulates Ca(2+)/calmodulin-dependent endothelial nitric oxide synthase activity. Circ Res (2001) 3.18
Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI): mechanistic insights from serial contrast-enhanced magnetic resonance imaging. Circulation (2003) 2.97
Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation (2001) 2.95
Suppression of apoptosis by nitric oxide via inhibition of interleukin-1beta-converting enzyme (ICE)-like and cysteine protease protein (CPP)-32-like proteases. J Exp Med (1997) 2.76
Fluid shear stress stimulates phosphorylation of Akt in human endothelial cells: involvement in suppression of apoptosis. Circ Res (1998) 2.70
Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginine. Lancet (1992) 2.66
Platelet glycoprotein IIIa polymorphisms and risk of coronary stent thrombosis. Lancet (1997) 2.36
Effect of filgrastim treatment on inflammatory cytokines and lymphocyte functions. Clin Pharmacol Ther (1999) 2.33
Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease. Circulation (2000) 2.18
Quantitative assessment of coronary vasoreactivity in humans in vivo. Importance of baseline vasomotor tone in atherosclerosis. Circulation (1995) 2.16
Posttranslational modification of Bcl-2 facilitates its proteasome-dependent degradation: molecular characterization of the involved signaling pathway. Mol Cell Biol (2000) 2.07
The role of toll-like receptors (TLRs) in bacteria-induced maturation of murine dendritic cells (DCS). Peptidoglycan and lipoteichoic acid are inducers of DC maturation and require TLR2. J Biol Chem (2001) 2.04
Dephosphorylation targets Bcl-2 for ubiquitin-dependent degradation: a link between the apoptosome and the proteasome pathway. J Exp Med (1999) 1.99
Akt-dependent phosphorylation of p21(Cip1) regulates PCNA binding and proliferation of endothelial cells. Mol Cell Biol (2001) 1.98
Phosphorylation of the endothelial nitric oxide synthase at ser-1177 is required for VEGF-induced endothelial cell migration. FEBS Lett (2000) 1.97
Akt takes center stage in angiogenesis signaling. Circ Res (2000) 1.96
Nitric oxide inhibits caspase-3 by S-nitrosation in vivo. J Biol Chem (1999) 1.78
Endothelial cell apoptosis in angiogenesis and vessel regression. Circ Res (2000) 1.73
Nitric oxide-an endothelial cell survival factor. Cell Death Differ (1999) 1.70
Phosphorylation and activation of the endothelial nitric oxide synthase by fluid shear stress. Acta Physiol Scand (2000) 1.61
A trauma-like elevation of plasma cytokines in humans in response to treadmill running. J Physiol (1998) 1.59
Shear stress inhibits apoptosis of human endothelial cells. FEBS Lett (1996) 1.58
Allele-specific regulation of matrix metalloproteinase-12 gene activity is associated with coronary artery luminal dimensions in diabetic patients with manifest coronary artery disease. Circ Res (2000) 1.52
Insulin-mediated stimulation of protein kinase Akt: A potent survival signaling cascade for endothelial cells. Arterioscler Thromb Vasc Biol (2000) 1.50
Effect of statin therapy on restenosis after coronary stent implantation. Am J Cardiol (2000) 1.50
Ubiquitin-mediated degradation of the proapoptotic active form of bid. A functional consequence on apoptosis induction. J Biol Chem (2000) 1.45
Nitric oxide inhibits dystrophin proteolysis by coxsackieviral protease 2A through S-nitrosylation: A protective mechanism against enteroviral cardiomyopathy. Circulation (2000) 1.44
Aging enhances the sensitivity of endothelial cells toward apoptotic stimuli: important role of nitric oxide. Circ Res (2001) 1.44
Statin therapy is associated with reduced restenosis rates after coronary stent implantation in carriers of the Pl(A2)allele of the platelet glycoprotein IIIa gene. Eur Heart J (2001) 1.42
Angiotensin II induces apoptosis of human endothelial cells. Protective effect of nitric oxide. Circ Res (1997) 1.41
[Spontaneous remission of Goodpasture syndrome in a 21-year-old patient]. Dtsch Med Wochenschr (1999) 1.38
Apoptosis of endothelial cells. Contribution to the pathophysiology of atherosclerosis? Eur Cytokine Netw (1998) 1.35
Nitric oxide and apoptosis: another paradigm for the double-edged role of nitric oxide. Nitric Oxide (1997) 1.33
Oxidized low-density lipoprotein induces apoptosis of human endothelial cells by activation of CPP32-like proteases. A mechanistic clue to the 'response to injury' hypothesis. Circulation (1997) 1.31
Upregulation of superoxide dismutase and nitric oxide synthase mediates the apoptosis-suppressive effects of shear stress on endothelial cells. Arterioscler Thromb Vasc Biol (1999) 1.31
Nitric oxide activates telomerase and delays endothelial cell senescence. Circ Res (2000) 1.29
Cardiovascular risk factors in primary care: methods and baseline prevalence rates--the DETECT program. Curr Med Res Opin (2005) 1.29
Allele-specific regulation of matrix metalloproteinase-7 promoter activity is associated with coronary artery luminal dimensions among hypercholesterolemic patients. Arterioscler Thromb Vasc Biol (2001) 1.28
Shear stress inhibits H2O2-induced apoptosis of human endothelial cells by modulation of the glutathione redox cycle and nitric oxide synthase. Arterioscler Thromb Vasc Biol (1997) 1.26
Congestive heart failure induces endothelial cell apoptosis: protective role of carvedilol. J Am Coll Cardiol (2000) 1.22
Enzymatic synthesis of lignin: purification to homogeneity of the three O-methyltransferases of tobacco and production of specific antibodies. Arch Biochem Biophys (1987) 1.19
Chronic periodontal disease is associated with single-nucleotide polymorphisms of the human TLR-4 gene. Genes Immun (2005) 1.18
Tumor necrosis factor antagonism with etanercept improves systemic endothelial vasoreactivity in patients with advanced heart failure. Circulation (2001) 1.17
Flow-dependent coronary artery dilatation in humans. Circulation (1989) 1.16
TNFalpha and oxLDL reduce protein S-nitrosylation in endothelial cells. J Biol Chem (2001) 1.15
Compliance assessed by the Medication Event Monitoring System. Arch Dis Child (1991) 1.15
Critical comparison of novel and existing methods of compliance assessment during a clinical trial of an oral iron chelator. J Clin Pharmacol (1994) 1.15
Nitric oxide down-regulates MKP-3 mRNA levels: involvement in endothelial cell protection from apoptosis. J Biol Chem (2000) 1.13
Cyclosporin A inhibits apoptosis of human endothelial cells by preventing release of cytochrome C from mitochondria. Circulation (1998) 1.11
Apoptosis in the vascular wall and atherosclerosis. Basic Res Cardiol (2001) 1.11
Factors influencing apnea and bradycardia of prematurity - implications for neurodevelopment. Neonatology (2006) 1.11
Acute myeloblastic leukaemia in sarcoidosis treated with methotrexate. Scand J Haematol (1980) 1.11
Coronary stent grafts covered by a polytetrafluoroethylene membrane. Am J Cardiol (1999) 1.09
Reactive oxygen species and vascular cell apoptosis in response to angiotensin II and pro-atherosclerotic factors. Regul Pept (2000) 1.08
Results of Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) trial. Circulation (2002) 1.06
Unmet needs in the diagnosis and treatment of dyslipidemia in the primary care setting in Germany. Atherosclerosis (2006) 1.05
Vitamin C and E prevent lipopolysaccharide-induced apoptosis in human endothelial cells by modulation of Bcl-2 and Bax. Eur J Pharmacol (1996) 1.05
Co-expression of p53 and MDM2 in human atherosclerosis: implications for the regulation of cellularity of atherosclerotic lesions. J Pathol (1998) 1.04
Pro-atherogenic factors induce telomerase inactivation in endothelial cells through an Akt-dependent mechanism. FEBS Lett (2001) 1.04
Vitamin C inhibits endothelial cell apoptosis in congestive heart failure. Circulation (2001) 1.03
Comparison of oral iron chelator L1 and desferrioxamine in iron-loaded patients. Lancet (1990) 1.03
Upregulation of TRAF-3 by shear stress blocks CD40-mediated endothelial activation. J Clin Invest (2001) 1.00